NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/26/2024
Back to search
Official data from USPTO
ALYGLO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
01/10/2025
Trademark type
Word
Nice classes
5
Filing date
09/04/2020
Registration date
11/26/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
01/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/08/2024
First use in commerce
07/08/2024
Drawing code
4
Owner type
03
Owner location
Yongin-si, Gyeonggi-do, KR
Examiner
HOWELL,MATTHEW PATTERSON
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
GC BIOPHARMA CORP.
G. C. (pessoa física)
Representatives
KWANG YUP CHAE Hauptman Ham, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Blood plasma derivatives for medical purposesimmune globulins including Rh immune globulin; Immunoglobulin reparationspharmaceutical immunoglobulin preparations for treatment of primary humoral immunodeficiencyKawasaki diseaseGuillain-Barre syndromecommon variable immune deficiencyX-linked agammaglobulinemia (XLA)hyper immunoglobulin M syndromesWiskott Aldrich Syndrome and severe combined immune deficiency (SCID)agammaglobulinemiahypogammaglobulinemiacardiovascular diseaseinflammatory diseasesimmunological disordersbacterial infectionsacute serious bacterial infectionchronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP); all the foregoing for patient treatment by injection or in liquid form by health professional
Publications
History of USPTO decisions and trademark events.
51 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/24/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/24/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/24/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/23/2024
IUAF
USE AMENDMENT FILED
08/19/2024
EISU
TEAS STATEMENT OF USE RECEIVED
08/19/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/03/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/15/2024
EX4G
SOU EXTENSION 4 GRANTED
02/14/2024
EXT4
SOU EXTENSION 4 FILED
02/14/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/14/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/30/2023
EX3G
SOU EXTENSION 3 GRANTED
08/28/2023
EXT3
SOU EXTENSION 3 FILED
08/28/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/28/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/24/2023
EX2G
SOU EXTENSION 2 GRANTED
02/22/2023
EXT2
SOU EXTENSION 2 FILED
02/22/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/22/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/04/2022
EX1G
SOU EXTENSION 1 GRANTED
08/02/2022
EXT1
SOU EXTENSION 1 FILED
08/02/2022
EEXT
SOU TEAS EXTENSION RECEIVED
08/02/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/24/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/24/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/24/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/24/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/01/2022
CHPB
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
02/07/2022
APET
ASSIGNED TO PETITION STAFF
02/02/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
01/26/2022
TMBN
TTAB RELEASE CASE TO TRADEMARKS
01/20/2022
OP.T
OPPOSITION TERMINATED NO. 999999
01/20/2022
OP.D
OPPOSITION DISMISSED NO. 999999
01/20/2022
OP.I
OPPOSITION INSTITUTED NO. 999999
10/18/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/20/2021
PUBO
PUBLISHED FOR OPPOSITION
04/20/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/31/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/10/2021
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
01/13/2021
GPRA
PRIORITY ACTION E-MAILED
01/13/2021
CPRA
PRIORITY ACTION WRITTEN
01/13/2021
DOCK
ASSIGNED TO EXAMINER
01/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/09/2020
NWAP
NEW APPLICATION ENTERED
09/08/2020
Continuous trademark protection
Get notified about every new filing that threatens ALYGLO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.